Literature DB >> 33762641

Protein cleavage influences surface protein presentation in Mycoplasma pneumoniae.

Iain J Berry1,2, Michael Widjaja1,2, Veronica M Jarocki1, Joel R Steele2,3, Matthew P Padula2,3, Steven P Djordjevic4.   

Abstract

Mycoplasma pneumoniae is a significant cause of pneumonia and post infection sequelae affecting organ sites distant to the respiratory tract are common. It is also a model organism where extensive 'omics' studies have been conducted to gain insight into how minimal genome self-replicating organisms function. An N-terminome study undertaken here identified 4898 unique N-terminal peptides that mapped to 391 (56%) predicted M. pneumoniae proteins. True N-terminal sequences beginning with the initiating methionine (iMet) residue from the predicted Open Reading Frame (ORF) were identified for 163 proteins. Notably, almost half (317; 46%) of the ORFS derived from M. pneumoniae strain M129 are post-translationally modified, presumably by proteolytic processing, because dimethyl labelled neo-N-termini were characterised that mapped beyond the predicted N-terminus. An analysis of the N-terminome describes endoproteolytic processing events predominately targeting tryptic-like sites, though cleavages at negatively charged residues in P1' (D and E) with lysine or serine/alanine in P2' and P3' positions also occurred frequently. Surfaceome studies identified 160 proteins (23% of the proteome) to be exposed on the extracellular surface of M. pneumoniae. The two orthogonal methodologies used to characterise the surfaceome each identified the same 116 proteins, a 72% (116/160) overlap. Apart from lipoproteins, transporters, and adhesins, 93/160 (58%) of the surface proteins lack signal peptides and have well characterised, canonical functions in the cell. Of the 160 surface proteins identified, 134 were also targets of endo-proteolytic processing. These processing events are likely to have profound implications for how the host immune system recognises and responds to M. pneumoniae.

Entities:  

Year:  2021        PMID: 33762641     DOI: 10.1038/s41598-021-86217-y

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  62 in total

1.  Re-annotating the Mycoplasma pneumoniae genome sequence: adding value, function and reading frames.

Authors:  T Dandekar; M Huynen; J T Regula; B Ueberle; C U Zimmermann; M A Andrade; T Doerks; L Sánchez-Pulido; B Snel; M Suyama; Y P Yuan; R Herrmann; P Bork
Journal:  Nucleic Acids Res       Date:  2000-09-01       Impact factor: 16.971

Review 2.  Exported proteins in probiotic bacteria: adhesion to intestinal surfaces, host immunomodulation and molecular cross-talking with the host.

Authors:  Borja Sánchez; Philippe Bressollier; María C Urdaci
Journal:  FEMS Immunol Med Microbiol       Date:  2008-07-08

3.  Complete sequence analysis of the genome of the bacterium Mycoplasma pneumoniae.

Authors:  R Himmelreich; H Hilbert; H Plagens; E Pirkl; B C Li; R Herrmann
Journal:  Nucleic Acids Res       Date:  1996-11-15       Impact factor: 16.971

4.  Large-scale metabolome analysis and quantitative integration with genomics and proteomics data in Mycoplasma pneumoniae.

Authors:  Tobias Maier; Josep Marcos; Judith A H Wodke; Bernhard Paetzold; Manuel Liebeke; Ricardo Gutiérrez-Gallego; Luis Serrano
Journal:  Mol Biosyst       Date:  2013-04-19

Review 5.  Pathogenesis of extrapulmonary manifestations of Mycoplasma pneumoniae infection with special reference to pneumonia.

Authors:  Mitsuo Narita
Journal:  J Infect Chemother       Date:  2010-02-27       Impact factor: 2.211

6.  Mycoplasma pneumoniae infection in a clinical setting.

Authors:  Norlijah Othman; David Isaacs; Andrew J Daley; Alison M Kesson
Journal:  Pediatr Int       Date:  2008-10       Impact factor: 1.524

Review 7.  Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infections.

Authors:  Thomas Prescott Atkinson; Mitchell F Balish; Ken B Waites
Journal:  FEMS Microbiol Rev       Date:  2008-08-27       Impact factor: 16.408

8.  Defining a minimal cell: essentiality of small ORFs and ncRNAs in a genome-reduced bacterium.

Authors:  Maria Lluch-Senar; Javier Delgado; Wei-Hua Chen; Verónica Lloréns-Rico; Francis J O'Reilly; Judith Ah Wodke; E Besray Unal; Eva Yus; Sira Martínez; Robert J Nichols; Tony Ferrar; Ana Vivancos; Arne Schmeisky; Jörg Stülke; Vera van Noort; Anne-Claude Gavin; Peer Bork; Luis Serrano
Journal:  Mol Syst Biol       Date:  2015-01-21       Impact factor: 11.429

9.  Defined chromosome structure in the genome-reduced bacterium Mycoplasma pneumoniae.

Authors:  Marie Trussart; Eva Yus; Sira Martinez; Davide Baù; Yuhei O Tahara; Thomas Pengo; Michael Widjaja; Simon Kretschmer; Jim Swoger; Steven Djordjevic; Lynne Turnbull; Cynthia Whitchurch; Makoto Miyata; Marc A Marti-Renom; Maria Lluch-Senar; Luís Serrano
Journal:  Nat Commun       Date:  2017-03-08       Impact factor: 14.919

10.  Periodicity in Attachment Organelle Revealed by Electron Cryotomography Suggests Conformational Changes in Gliding Mechanism of Mycoplasma pneumoniae.

Authors:  Akihiro Kawamoto; Lisa Matsuo; Takayuki Kato; Hiroki Yamamoto; Keiichi Namba; Makoto Miyata
Journal:  mBio       Date:  2016-04-12       Impact factor: 7.867

View more
  3 in total

Review 1.  Beware of Mycoplasma Anti-immunoglobulin Strategies.

Authors:  Yonathan Arfi; Carole Lartigue; Pascal Sirand-Pugnet; Alain Blanchard
Journal:  mBio       Date:  2021-11-16       Impact factor: 7.867

2.  Multiple bacterial virulence factors focused on adherence and biofilm formation associate with outcomes in cirrhosis.

Authors:  Jasmohan S Bajaj; Amirhossein Shamsaddini; Chathur Acharya; Andrew Fagan; Masoumeh Sikaroodi; Edith Gavis; Sara McGeorge; Alexander Khoruts; Michael Fuchs; Richard K Sterling; Hannah Lee; Patrick M Gillevet
Journal:  Gut Microbes       Date:  2021 Jan-Dec

3.  Novel mycoplasma nucleomodulin MbovP475 decreased cell viability by regulating expression of CRYAB and MCF2L2.

Authors:  Gang Zhao; Doukun Lu; Shujuan Wang; Hui Zhang; Xifang Zhu; Zhiyu Hao; Ali Dawood; Yingyu Chen; Elise Schieck; Changmin Hu; Xi Chen; Liguo Yang; Aizhen Guo
Journal:  Virulence       Date:  2022-12       Impact factor: 5.428

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.